Empagliflozin Reduces Progression of Diabetic Retinopathy in Patients With High Risk of Diabetic Macular Edema

Stopped difficulties to recruit planned numbers of patients within reasonable time frame

Conditions

• Diabetes Mellitus, Type II

Interventions

• DRUG: Empagliflozin
• DRUG: Glimepiride
• DRUG: Empagliflozin placebo
• DRUG: Glimepiride placebo

Sponsor

Hannover Medical School